Very happy to share this work on a preprint! Coauthored with @mikebrowning.bsky.social @Erdem Pulcu @lhuntneuro.bsky.social
www.biorxiv.org/content/10.6...
How do we learn when rewards and punishments change independently—and how does this go awry in anxiety and depression?
RA jobs in Oxford working on a Wellcome Trust funded grant. Neuroimaging, neurostimulation, computational modelling-- what's not to like!
my.corehr.com/pls/uoxrecru...
📣🔥Thrilled to announce that 2026 Computational Psychiatry Conference will take place in New Haven, CT, btw July 14-16 -
www.cpconf.org
@robbrutledge.bsky.social @drrickadams.bsky.social @tobiasuhauser.bsky.social @docqhuys.bsky.social @clairegillan.bsky.social Sonia Bishop
More info to come soon!
This project builds on work establishing the behaviour done at Champalimaud in Lisbon with @michaelfsp.bsky.social, Beatriz Godinho, Christian Machens, and @ruimcosta.bsky.social : www.biorxiv.org/content/10.6...
This #ClinicalTrialsDay (20 May), we’re promoting studies seeking participants.
RELMED aims to improve #depression treatment by predicting which #antidepressant works best.
If eligible, you may be able to take part.
Find out more or register interest:
[email protected]
relmed.ac.uk
Repetitive negative thoughts will be investigated using a range of cutting-edge brain science techniques as part of a new study led by the Department of Psychiatry, University of Oxford and funded by Wellcome @wellcometrust.bsky.social 👇
tinyurl.com/364es88k
Postdoctoral research position in #ComputationalPsychiatry and #EEG as part of relmed.ac.uk trial testing reinforcement learning as biomarker for antidepressant treatment response. www.ucl.ac.uk/work-at-ucl/... @uclbrainscience.bsky.social @mikebrowning.bsky.social @relmed.bsky.social
Michael Browning
Just out today, the keto diet showed a (modest) benefit in treatment resistant depression, when compared to a pretty reasonable control! jamanetwork.com/journals/jam...
What a fantastic trial!
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial - The Lancet www.thelancet.com/journals/lan...
These posts are live now! Oxford is a great place to work. Do apply if you'd like to apply neurostimulatory techniques to understand symptoms.
my.corehr.com/pls/uoxrecru...
my.corehr.com/pls/uoxrecru...
Wanjun Lin
The ability to seek reward and avoid punishment is a fundamental survival instinct. In natural environments, however, the statistics of rewards and punishments can change independently of one another....
Action selection using predictive models of the environment plays a fundamental role in human and animal behaviour, yet is poorly understood at circuit and algorithmic levels. Spatial navigation is an...
www.biorxiv.org
Antidepressant treatment shouldn't be a guessing game. RELMED is working towards using advanced research to predict which medication is most likely to help each person along their individual path to recovery.
relmed.ac.uk
This randomized clinical trial assesses the effect of a ketogenic diet on mental health outcomes in individuals with treatment-resistant depression.
Semaglutide showed robust therapeutic effects in treatment-seeking participants with
obesity and alcohol use disorder and this trial supports previous preclinical and
clinical findings suggesting GLP-...
There are 3 Oxford-based post doc positions for this Wellcome Trust project that will be advertised soon!
If you have experinece in neurostimulation (tms/tus) and/or modelling of cogneuro data in humans do contact one of us (me, @mkflugge.bsky.social @lilweb.bsky.social, Jacinta OShea) to discuss!
Michael Browning
Repetitive negative thoughts will be investigated using a range of cutting-edge brain science techniques as part of a new study led by the Department of Psychiatry, University of Oxford and funded by Wellcome @wellcometrust.bsky.social 👇
tinyurl.com/364es88k
